Impact story: Medicines Patent Pool

Review of the Pibrentasvir patent landscape: A scoping report

Review of the Glecaprevir patent landscape: A scoping report

Unitaid’s approach to intellectual property

Thematic Narrative for Reproductive, Maternal, Newborn and Child Health (RMNCH)

Discussion Paper: Ensuring that essential medicines are also affordable medicines: challenges and options

Discussion Paper: An economic perspective on delinking the cost of R&D from the price of medicines

Hepatitis C medicines technology and market landscape